Physician profile
Lance Berlin
NPI 1942262241
$2,913.82
in general payments reported to CMS, 2019-2025
13 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,566 · 2020: $46.94 · 2022: $71.16 · 2023: $49.63 · 2024: $32.16 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hypermed Imaging INC. | $2,525.67 | 2019 | |
| Smith+Nephew, INC. | $102.84 | 2022-2025 | Grafix, Collagenase Santyl, Grafix Pl |
| Bioventus LLC | $42.64 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Osteomed LLC | $41.31 | 2019-2022 | |
| Djo, LLC | $34.47 | 2025 | Cmf |
| Averitas Pharma INC. | $33.26 | 2025 | Qutenza |
| Kerecis Limited | $32.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $27.83 | 2025 | |
| Stryker Corporation | $23.33 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.68 | 2023 | Nuzyra |
| Davol INC. | $12.26 | 2020 | |
| Arthrosurface Incorporated | $12.02 | 2019 | |
| Integra Lifesciences Corporation | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Berlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.